These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Early recognition of risk factors for persistent effects of vecuronium. Sanders KA; Aucker R South Med J; 1996 Apr; 89(4):411-4. PubMed ID: 8614883 [TBL] [Abstract][Full Text] [Related]
7. Prolonged weakness and vecuronium. Scott VL; Freeman JA; DeWolf AM Ann Intern Med; 1993 Apr; 118(7):570; author reply 571. PubMed ID: 8095131 [No Abstract] [Full Text] [Related]
8. Comparison of large dose of vecuronium with pancuronium for prolonged neuromuscular blockade. Rørvik K; Husby P; Gramstad L; Vamnes JS; Bitsch-Larsen L; Koller ME Br J Anaesth; 1988 Aug; 61(2):180-5. PubMed ID: 2901270 [TBL] [Abstract][Full Text] [Related]